Preview

Acta Biomedica Scientifica

Advanced search

Dynamics of myocardial necrosis biomarkers and acid-base balance parameters after coronary artery bypass grafting on beating-heart depending on the perioperative glucose-lowering treatment regimen in patients with type II diabetes

Abstract

The study included 71 patient with ischemic coronary disease (ICD) with type II diabetes mellitus (DM) treated by oral hypoglycemic agents undergoing off-pump coronary artery bypass grafting (CABG). The mean age was 59 (56-64) years. Before the surgery the patients were randomized to continuing of oral hypoglycemic agents (n = 34) or to switching to rapid-acting insulin (n = 37). In the studied groups we compared glycemic parameters, markers of myocardial necrosis (troponin T and creatinine phosphokinase-MB (CPK-MB)) and acid-base balance, as well as their dynamics during the perioperative period. The relationships of myocardial necrosis markers dynamics with glucose metabolism and acid-base balance parameters were investigated. Before the surgery in switched to rapid-acting insulin patients serum glucose, its daily variability and the proportion of blood glucose values less than recommended perioperative range (6,1-10,0 mmol/l) were higher than in those at oral hypoglycemic agents. The myocardial necrosis markers at the day before and 24 h after surgery as well as lactate level and blood acidity during and at 24 hours after surgery were higher in the insulin-group. The insulin-group was characterized by greater increase of troponin T during 24 h after surgery (0,36 [0,25-0,40] vs 0,2 [0,1-0,25] ng/ml; p < 0,001) and CPK-MB (14 [8,0-17,0] vs 7,3 [1,5-8,7] U/L; p < 0,001). Troponin T and CPK-MB dynamics correlated with serum glucose during surgery (r = +0,81 and r = +0,66 respectively), daily serum glucose variability at the day before surgery (r = +0,71 and r = +0,63) and the first day of admission to hospital (r = +0,37 and r = +0,31).

About the Authors

S. Y. Borodashkina
Irkutsk Regional Clinical Hospital
Russian Federation


K. V. Protasov
Irkutsk State Medical Academy of Continuing Education
Russian Federation


V. A. Podkamennyi
Irkutsk State Medical Academy of Continuing Education
Russian Federation


References

1. Гибельгаус М.А., Кремнева Л.В., Нелаев B.C., Крючев Н.В., Абатурова О.В. Оценка взаимосвязи уровня тропонина Т после коронарного шунтирования с клинико-ангиографическими характеристиками и показателями оперативного вмешательства у больных ИБС // Матер. V съезда кардиологов Уральского федерального округа. - Екатеринбург, 2011. - С. 94

2. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом», 7 выпуск // Сахарный диабет. -2015. - № 18 (1S). - С. 1-112

3. Дедов И.И., Шестакова М.В., Максимова М.А. Федеральная целевая программа «Сахарный диабет»: Метод. рекомендации. - М., 2002

4. Комиссарова Е.С., Беляева Н.Г., Тезяева С.А., Стронгин Л.Г. Интенсивная инсулинотерапия у больных хирургического профиля с сахарным диабетом 2-го типа // Современные технологии в медицине. - 2013. - T. 5, № 1. - С. 64-69

5. Рекомендации по лечению стабильной ишемической болезни сердца. ESC 2013 // Российский кардиологический журнал. - 2014. - № 7 (111). - С. 7-79

6. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart]., 34, 3035-3087.

7. ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart]., 35 (37), 2541-2619.

8. Bansilal S., Farkouh M.E., Hueb W. (2012). The future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am. Heart]., 164 (4), 591-599.

9. Deedwania P., Kosiborod M., Barrett E. et al. (2008) Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation, 117, 1610-1619.

10. Duckworth W., Abraira C., Moritz T. et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl.]. Med., 360 (2), 129-139.

11. Jacobi J., Bircher N., Krinsley J. et al. (2012). Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit. Care Med., 40, 3251-3276.

12. Marik P.E., Preiser J.C. (2010). Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest, 137, 544-551.

13. Nashef S.A., Roques F., Sharples L.D. et al. (2012.) EuroSCORE II. Eur.]. Cardiothorac. Surg., 41 (4), 734-744.

14. Saisho Y. (2014). Glycemic variability and oxidative stress: A link between diabetes and cardiovascular disease? Int.]. Mol. Sci., 15, 18381-18406.

15. Skyler J.S., Bergenstal R., Bonow B.O. et al. (2009). Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 32, 187-192.

16. Subramaniam B., Lerner A., Novack V. et al. (2014). Increased glycemic variability in patients with elevated preoperative HbA1c predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth. Analg, 118 (2), 277-287.

17. The BARI 2D Study Group: A randomized trial of therapies for type 2 diabetes and coronary artery disease (2009) N. Engl.]. Med., 360, 2503-2515.

18. Thygesen K., Alpert J.S., Jaffe A.S. et al. (2012). Third universal definition of myocardial infarction. Eur. Heart]., 33 (20), 2551-2567.

19. U.K. Hypoglycaemia Study Group (2007). Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.


Review

For citations:


Borodashkina S.Y., Protasov K.V., Podkamennyi V.A. Dynamics of myocardial necrosis biomarkers and acid-base balance parameters after coronary artery bypass grafting on beating-heart depending on the perioperative glucose-lowering treatment regimen in patients with type II diabetes. Acta Biomedica Scientifica. 2015;(6):11-16. (In Russ.)

Views: 438


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)